Planet Green Holdings Corp. filed a Current Report on Form 8-K on November 19, 2026, disclosing that its subsidiary Hubei Taihe Biotechnology Co., Ltd. entered into a technology transfer agreement on November 17, 2026, to acquire a registered immune-support health food product from Harbin Aikesailun Biotechnology Co., Ltd. for RMB1,550,000 (US$232,500).
Key Highlights
- Agreement date: The technology transfer agreement was executed on November 17, 2026, between Hubei Taihe Biotechnology Co., Ltd. and Harbin Aikesailun Biotechnology Co., Ltd.
- Product acquired: The agreement covers the Aikesailun-branded bovine colostrum, vitamin C and lactoferrin chewable tablets, described in the filing as a registered immune-support health food product.
- Purchase consideration: Taihe Bio agreed to pay RMB1,550,000 (US$232,500) to Aikesailun Bio for the acquisition.
- Assets transferred: The transfer includes the product's proprietary formulation, production process, quality standards, related technical know-how, and the associated health food registration certificate rights in China.
- Additional costs: Taihe Bio is responsible for certain transfer-related costs, including notarization, sample production, and testing, according to the filing.
- Seller obligations: Aikesailun Bio will provide technical materials and assistance with the transfer and registration process.
Planet Green Subsidiary Enters Health Food Technology Transfer in China
According to the Form 8-K filed with the Securities and Exchange Commission, Hubei Taihe Biotechnology Co., Ltd., a subsidiary of Planet Green Holdings Corp. (NYSE American:PLAG), entered into a technology transfer agreement with Harbin Aikesailun Biotechnology Co., Ltd. on November 17, 2026. The agreement provides for Taihe Bio to acquire rights to a registered health food product consisting of bovine colostrum, vitamin C, and lactoferrin chewable tablets sold under the Aikesailun brand.
The filing states that the consideration for the acquisition is RMB1,550,000 (US$232,500), to be paid by Taihe Bio to Aikesailun Bio. Beyond the stated purchase price, the company disclosed that Taihe Bio bears responsibility for certain transfer-related costs, specifically notarization, sample production, and testing. In connection with the transaction, Aikesailun Bio is obligated to supply technical materials and to assist with the transfer and registration process.
The company noted that the assets being acquired include the product's proprietary formulation, production process, quality standards, related technical know-how, and the health food registration certificate rights in China. The filing states that the Transfer Agreement also contains provisions regarding payment suspension, delays, and termination, and that the full agreement is filed as Exhibit 10.1 to the Current Report. The company also issued a press release on November 17, 2026, announcing the transaction, attached as Exhibit 99.1.
What Was Disclosed
Planet Green Holdings Corp. reported that its subsidiary entered a technology transfer agreement to acquire a registered Chinese health food product for RMB1,550,000 (US$232,500), including the formulation, production process, quality standards, technical know-how, and registration certificate rights.



Please wait processing your request...